SCHEMBL5588710

SCHEMBL5588710

CCc1c(O)c(O)c(Cl)c(Cl)c1CC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 3/20 0.38
MEN1 O00255 2/20 0.38
LMNA P02545 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 4/20 0.35
CYP2C9 P11712 3/20 0.35
HIF1A Q16665 3/20 0.35
MAPK1 P28482 2/20 0.35
CYP2C19 P33261 2/20 0.32
NPC1 O15118 1/20 0.30
USP2 O75604 1/20 0.30
EGFR P00533 1/20 0.30
ESR1 P03372 1/20 0.30
ERBB2 P04626 1/20 0.30
LCK P06239 1/20 0.30
FYN P06241 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5589774 0.90 HPGD (0.32) TSHRHPGDHSD17B10MEN1LMNA
SCHEMBL5588038 0.90 TSHR (0.45) TSHRHPGDHSD17B10MEN1LMNA
SCHEMBL9304826 0.81 TSHR (0.47) TSHRHPGDHSD17B10MEN1LMNA
SCHEMBL5587147 0.76 GABRA1 (0.36)
SCHEMBL14274017 0.76
SCHEMBL5588282 0.75 TSHR (0.41) TSHRHPGDHSD17B10MEN1LMNA
SCHEMBL5589670 0.75 HPGD (0.35) TSHRHPGDHSD17B10MEN1LMNA
SCHEMBL7179070 0.75 HPGD (0.35) TSHRHPGDHSD17B10MEN1LMNA
SCHEMBL5587989 0.73 LDHA (0.37) HSD17B10
SCHEMBL5587226 0.73 AHR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 TSHR 4680/4885HPGD 2689/4885HSD17B10 1640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.